OmniAb, Inc.
OABIW- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001846253
No open-market purchases or sales by OmniAb, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $238.9K in total; no superinvestor holds it.
Other share classesOABI
Q2 2023 vs. Q1 2023
How the institutions holding OmniAb, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 22 | 21 | −1 |
| Shares | 5.45M | 5.80M | +343.4K (+6.3%) |
| Value | $3.74M | $4.44M | +$701.7K (+18.8%) |
New holders (2)
Institutions that held OmniAb, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Privium Fund Management B.V. | 652,078 | $482.5K | 0.14% |
| Sea Otter Advisors LLC | 50,000 | $38.5K | 0.03% |
Sold out (3)
Institutions that held OmniAb, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Highbridge Capital Management LLC | – | $107.0K |
| UBS Group AG | 250 | $138 |
| Boothbay Fund Management, LLC | 218,768 | – |